Creatinine normalization approach to diluted urine samples screened by LC-MS/MS method
Objectives: Urine is the most used matrix in drug analysis; however, it is susceptible to adulteration or tampering. Urine creatinine is the most important urine integrity parameter used as an indicator of dilution. This study aimed to evaluate the prevalence of diluted urine samples and the change...
Saved in:
Published in | International Journal of Medical Biochemistry Vol. 7; no. 2; pp. 95 - 100 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Istanbul
KARE Publishing
2024
Kare Publishing |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Objectives: Urine is the most used matrix in drug analysis; however, it is susceptible to adulteration or tampering. Urine creatinine is the most important urine integrity parameter used as an indicator of dilution. This study aimed to evaluate the prevalence of diluted urine samples and the change in positivity after creatinine normalization. Methods: Urine samples screened by the LC-MS/MS method over a 3.5-year period (n=21,927) were included in the study. Positivity rates were evaluated in both total and diluted urine samples. Additionally, the impact of creatinine normalization on samples with substance concentrations above the limit of quantitation (LOQ) and below the cut-off was investigated. Results: A total of 350,832 tests were conducted on 21,927 urine samples, resulting in an overall positivity rate of 21.2% (n=4652). The ratio of diluted urine was 1.6% (n=343), with 61.5% (n=211) testing negative (<LOQ), 23.3% (n=80) testing positive (at least one substance >cut-off), and 15.2% (n=52) testing above LOQ and below cut-off. After creatinine normalization in diluted urines, the sample positivity rate increased from 23.3% (n=80) to 33.8% (n=116) (p <0.001), and the substance positivity rate increased from 2.3% (n=125) to 3.9% (n=212) (p <0.001). Conclusion: Precautions should be taken in reporting diluted urine samples to avoid reporting false negative results. The creatinine normalization approach shows promise in laboratories using quantitative screening methods such as LC-MS/MS for samples with substance concentrations above the LOQ and below the cut-off. However, more clinical and laboratory collaboration is needed for its routine application. Keywords: Creatinine normalization, diluted urine, illicit drug, screening test |
---|---|
AbstractList | Objectives: Urine is the most used matrix in drug analysis; however, it is susceptible to adulteration or tampering. Urine creatinine is the most important urine integrity parameter used as an indicator of dilution. This study aimed to evaluate the prevalence of diluted urine samples and the change in positivity after creatinine normalization. Methods: Urine samples screened by the LC-MS/MS method over a 3.5-year period (n=21,927) were included in the study. Positivity rates were evaluated in both total and diluted urine samples. Additionally, the impact of creatinine normalization on samples with substance concentrations above the limit of quantitation (LOQ) and below the cut-off was investigated. Results: A total of 350,832 tests were conducted on 21,927 urine samples, resulting in an overall positivity rate of 21.2% (n=4652). The ratio of diluted urine was 1.6% (n=343), with 61.5% (n=211) testing negative (<LOQ), 23.3% (n=80) testing positive (at least one substance >cut-off), and 15.2% (n=52) testing above LOQ and below cut-off. After creatinine normalization in diluted urines, the sample positivity rate increased from 23.3% (n=80) to 33.8% (n=116) (p <0.001), and the substance positivity rate increased from 2.3% (n=125) to 3.9% (n=212) (p <0.001). Conclusion: Precautions should be taken in reporting diluted urine samples to avoid reporting false negative results. The creatinine normalization approach shows promise in laboratories using quantitative screening methods such as LC-MS/MS for samples with substance concentrations above the LOQ and below the cut-off. However, more clinical and laboratory collaboration is needed for its routine application. Keywords: Creatinine normalization, diluted urine, illicit drug, screening test [LANGUAGE= "English"] INTRODUCTION: Urine is the most used matrix in drug analysis; however, it is susceptible to adulteration or tampering. Urine creatinine is the most important urine integrity parameter used as an indicator of dilution. This study aimed to evaluate the prevalence of diluted urine samples and the change in positivity after creatinine normalization.METHODS: Urine samples screened by the LC-MS/MS method over a 3.5-year period (n=21,927) were included in the study. Positivity rates were evaluated in both total and diluted urine samples. Additionally, the impact of creatinine normalization on samples with substance concentrations above the limit of quantitation (LOQ) and below the cut-off was investigated.RESULTS: A total of 350,832 tests were conducted on 21,927 urine samples, resulting in an overall positivity rate of 21.2% (n=4652). The ratio of diluted urine was 1.6% (n=343), with 61.5% (n=211) testing negative (<LOQ), 23.3% (n=80) testing positive (at least one substance >cut-off), and 15.2% (n=52) testing above LOQ and below cut-off. After creatinine normalization in diluted urines, the sample positivity rate increased from 23.3% (n=80) to 33.8% (n=116) (p<0.001), and the substance positivity rate increased from 2.3% (n=125) to 3.9% (n=212) (p<0.001).DISCUSSION AND CONCLUSION: Precautions should be taken in reporting diluted urine samples to avoid reporting false negative results. The creatinine normalization approach shows promise in laboratories using quantitative screening methods such as LC-MS/MS for samples with substance concentrations above the LOQ and below the cut-off. However, more clinical and laboratory collaboration is needed for its routine application. |
Author | Uzen, Veysel Karakukcu, Cigdem Kocer, Derya Saracoglu, Hatice |
Author_xml | – sequence: 1 fullname: Karakukcu, Cigdem – sequence: 2 fullname: Kocer, Derya – sequence: 3 fullname: Uzen, Veysel – sequence: 4 fullname: Saracoglu, Hatice |
BookMark | eNptUc9PwyAUJmYmzrm7xyaeuwGlLRyXxl_JFg9T441QoI6lhQrtQf962WZiTHwcHu_L9z1477sEE-usBuAawQUiJSFLs-_qBYaYLPJYojMwxQWiaUHw2yTec1qmOCvwBZiHYGpIoghhRKbgtfJaDMYaqxPrfCda8xVrZxPR994JuUsGlyjTjoNWyegPvCC6vtUhCdJrbSNcfybrKt1sl5tt0ulh59QVOG9EG_T8J8_Ay93tc_WQrp_uH6vVOpWYUJRqJhjNGCJ5ARtJFVEZEgQVJSKKUVVGiBJY1BQhVsMyBpaM0EIx0WRKsWwGbk59418_Rh0Gvnejt_FJnkGWZ8c5f1nvotXc2MYNXsjOBMlXJcthXjBWRtbiH1Y8SndGxoU3JuJ_BPAkkN6F4HXDe2864T85gvzoCz_4wg--8KMv2TcLTYAv |
ContentType | Journal Article |
Copyright | COPYRIGHT 2024 KARE Publishing 2024. This work is published under https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: COPYRIGHT 2024 KARE Publishing – notice: 2024. This work is published under https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | AAYXX CITATION 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S PIMPY PQEST PQQKQ PQUKI PRINS |
DOI | 10.14744/ijmb.2024.57441 |
DatabaseName | CrossRef ProQuest Central (Corporate) ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China |
DatabaseTitle | CrossRef Publicly Available Content Database ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest One Academic ProQuest Central (Alumni) |
DatabaseTitleList | Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: 7X7 name: ProQuest Health & Medical Collection url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 2618-642X |
EndPage | 100 |
ExternalDocumentID | A795056997 10_14744_ijmb_2024_57441 |
GroupedDBID | AAYXX ALMA_UNASSIGNED_HOLDINGS CITATION M~E 3V. 7X7 7XB 8FI 8FJ 8FK AAFWJ ABDBF ABUWG AFKRA AFPKN ALIPV AZQEC BENPR CCPQU DWQXO EN8 FYUFA GROUPED_DOAJ HMCUK IAO IHR INH ITC K9. PIMPY PQEST PQQKQ PQUKI PRINS UKHRP |
ID | FETCH-LOGICAL-c2481-e9a983914560fc8d4d31a416714d98d7c8d8406b8119b077772c9486d9af3dd93 |
IEDL.DBID | 7X7 |
ISSN | 2587-2362 |
IngestDate | Thu Sep 19 06:21:26 EDT 2024 Wed May 29 17:42:02 EDT 2024 Tue May 28 06:11:27 EDT 2024 Fri Aug 23 01:48:38 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c2481-e9a983914560fc8d4d31a416714d98d7c8d8406b8119b077772c9486d9af3dd93 |
OpenAccessLink | https://www.proquest.com/docview/3095347412/abstract/?pq-origsite=%requestingapplication% |
PQID | 3095347412 |
PQPubID | 5083811 |
PageCount | 6 |
ParticipantIDs | proquest_journals_3095347412 gale_infotracmisc_A795056997 gale_infotracacademiconefile_A795056997 crossref_primary_10_14744_ijmb_2024_57441 |
PublicationCentury | 2000 |
PublicationDate | 2024-00-00 |
PublicationDateYYYYMMDD | 2024-01-01 |
PublicationDate_xml | – year: 2024 text: 2024-00-00 |
PublicationDecade | 2020 |
PublicationPlace | Istanbul |
PublicationPlace_xml | – name: Istanbul |
PublicationTitle | International Journal of Medical Biochemistry |
PublicationYear | 2024 |
Publisher | KARE Publishing Kare Publishing |
Publisher_xml | – name: KARE Publishing – name: Kare Publishing |
SSID | ssib044741214 ssj0002513684 |
Score | 2.2880821 |
Snippet | Objectives: Urine is the most used matrix in drug analysis; however, it is susceptible to adulteration or tampering. Urine creatinine is the most important... [LANGUAGE= "English"] INTRODUCTION: Urine is the most used matrix in drug analysis; however, it is susceptible to adulteration or tampering. Urine creatinine... |
SourceID | proquest gale crossref |
SourceType | Aggregation Database |
StartPage | 95 |
SubjectTerms | Analysis Collaboration Creatinine Laboratories Medical screening Methods Urine |
Title | Creatinine normalization approach to diluted urine samples screened by LC-MS/MS method |
URI | https://www.proquest.com/docview/3095347412/abstract/ |
Volume | 7 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LaxsxEBZOcsklNLQlzsPoUCg9bDZ6eLU6lcTYmFKb0sTFNyHtaMEhWSe1c8ilvz0z690EQ-geBCvti9Fo5pvRzgxjX0plswhlnoDwCg2Uskhybzw2Oooc9VMAih2eTLPxTP-Y9-cdNm5jYei3ylYm1oIalgX5yFNFidE06j-Z-kBegGKdfn94TKh-FO2zNsU0dtiekAgrkLPN_FWx6vrGZr-QZDRqdZXV5YhlH1eZRDHe7GHilTpd3N4HtB2lPu_jqdjSWe9L7lodjT6wgwZH8svNxB-yTqw-sj-DGgJWiBx5RWD0romy5G3qcL5eclggt0Xg5GePfOUpP_CKo_hAkxa7wzP_OUgm1-nkmm_qS39is9HwZjBOmsIJSSF1LpJovUXgIxAcIfFz0KCER-RlhAabg8EutOuykAthw4XBQxZW5xlYXyoAqz6z3WpZxSPGrekXQoEqg4261JReEFCrgwkSgpSmy761pHEPm_wYjuwKIqMjMjoio6vJ2GVfiXaOlg5NoG8iAPBNlITKXRpLeMxafOrp1pXI8sX2cEt91yy5lXtjkOP_D5-wffqmjR_llO2u_z7FM0QW69CrmabH9q6G01-_e7V9ju3k3_AFIZXMgg |
link.rule.ids | 315,786,790,870,4043,12083,21416,27956,27957,27958,31754,33779,43345,43840 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT9swELdG9wAviGkgGB_zw6SJh6z4o3H8NFUVVWEtL7RT3yw750hFW9rR8sB_v7vUBVVC5CFSHCuJfjnf_e5s3zH2rVI2j1AVGQiv0EGpyqzwxuNJR1GgfQpAe4dHd_lgom-nnWkKuC3TssqNTmwUNcxLipG3FSVG02j_5M_Fv4yqRtHsaiqhscM-aqU0Lekz0xdzqpvuaZaQNDPacpU3RYhlB8eWROWdZi6xp27PHv4G9Bil_tHBS7Flqd7W140R6h-w_cQeeXf9uz-xD7H-zH73GuJXI1_kNVHQP2lvJd8kDOerOYcZylgETtH1yJeesgIvOSoNdGSxOTzzYS8b3bdH93xdVfqQTfrX494gS-USslLqQmTReot0RyAlQsgL0KCER75lhAZbgMEm9ObyUAhhw5XBQ5ZWFzlYXykAq45Yq57X8ZhxazqlUKCqYKOuNCUVBLTlYIKEIKU5YZcbaNxinRXDkTdBMDqC0RGMroHxhH0n7BwNmNWjL31a949votRTrmsssTBr8alnWz1R0Mvt2xv0XRpoS_cqFl_ev_2V7Q7Go6Eb3tz9OmV79H3rSMoZa60en-I5cotVuGgE6D_RLsf1 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Creatinine+normalization+approach+to+diluted+urine+samples+screened+by+LC-MS%2FMS+method&rft.jtitle=International+Journal+of+Medical+Biochemistry&rft.au=Karakukcu%2C+Cigdem&rft.au=Kocer%2C+Derya&rft.au=Uzen%2C+Veysel&rft.au=Saracoglu%2C+Hatice&rft.date=2024&rft.pub=KARE+Publishing&rft.issn=2587-2362&rft.volume=7&rft.issue=2&rft.spage=95&rft_id=info:doi/10.14744%2Fijmb.2024.57441&rft.externalDocID=A795056997 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2587-2362&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2587-2362&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2587-2362&client=summon |